著者
Yutaro Akiyama Takeshi Inagaki Shinichiro Morioka Eiji Kusano Norio Ohmagari
出版者
The Japanese Society of Internal Medicine
雑誌
Internal Medicine (ISSN:09182918)
巻号頁・発行日
pp.1682-23, (Released:2023-04-21)
参考文献数
30
被引用文献数
2

A Japanese man experienced three episodes of hypovolemic shock and was diagnosed with systemic capillary leak syndrome (SCLS). He developed SCLS exacerbation 2 days after receiving a second dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine, 1 year after the third episode. After fluid therapy and albumin administration, we initiated terbutaline and theophylline prophylaxis for SCLS. A literature review revealed that SCLS attacks often occur 1-2 days after the second COVID-19 vaccination. Patients with a history of SCLS should avoid COVID-19 vaccination and be carefully monitored for 1-2 days if they receive the vaccine.

言及状況

外部データベース (DOI)

Twitter (130 users, 149 posts, 203 favorites)

日本からの論文 BNT162b2 mRNA COVID-19ワクチン接種後の特発性全身性毛細血管漏出症候群の増悪について https://t.co/rWOz9QbwaA ワクチン接種の1-2日後に起こることが多いことが判明した。SCLSの既往がある患者は、 ”COVID-19の接種を避け” 、接種した場合は1-2日間注意深く観察する必要がある。 https://t.co/0sm1ZAYpRc https://t.co/bAStWMpDbN
A 60-year-old man admitted to hospital with syncope. He noticed decreased urine output, right leg edema, nausea, dizziness, and dyspnea on exertion. As he stood up, he lost consciousness and was taken to the emergency department. 2nd dose #Pfizer #mRNA https://t.co/yhnmY8On5P https://t.co/UCH6WOqeGj

収集済み URL リスト